SCHEMBL28267331

SCHEMBL28267331

Cc1c(N)nc(N)nc1-c1ccc(S(=O)(=O)N2CCOCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
GAA P10253 3/20 0.52
POLB P06746 2/20 0.52
MEN1 O00255 2/20 0.52
ALDH1A1 P00352 7/20 0.52
KDM4E B2RXH2 7/20 0.52
HSD17B10 Q99714 6/20 0.52
HPGD P15428 5/20 0.52
USP2 O75604 1/20 0.51
JAK2 O60674 1/20 0.51
MAPK1 P28482 2/20 0.49
MAPT P10636 2/20 0.49
MMP14 P50281 1/20 0.49
LMNA P02545 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
TSHR P16473 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28265768 0.84 SMN1; SMN2 (0.50) KMT2AGAAMEN1ALDH1A1KDM4E
SCHEMBL6985080 0.79 KMT2A (0.60) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL4473290 0.77 POLB (0.53) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL17194217 0.74 KMT2A (0.73) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL12793245 0.73 POLB (0.88) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL17290538 0.73 KMT2A (0.52) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL17295351 0.73 KMT2A (0.52) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL15756908 0.73 KDM4E (0.52) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL10306750 0.72 POLB (0.73) KMT2AGAAPOLBMEN1ALDH1A1
SCHEMBL78621 0.72 POLB (0.73) KMT2AGAAPOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN disclosed
CN-106794181-A MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions 托马斯·黑勒戴药物研究基金会 2017-05-31 CN disclosed